Abionyx appoints chief digital and innovation officer

13 July 2023
abionyx_big

France’s Abionyx Pharma (Euronext: ABNX) today announced the appointment of Laurent Guerci as chief digital and innovation officer.

Abionyx s a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world's only natural recombinant ApoA-I. The company recently reported that the pilot Phase IIa trial of CER-001 as a treatment for septic patients at high risk of developing acute kidney injury (AKI) met its primary objective.

Mr Guerci is an agricultural engineer and graduate of the CPA (executive MBA), who has spent his entire career in information systems, first as the founding director of a company specialized in ERP for agricultural applications, which he sold, then as consulting director in information systems at PWC, and finally as director of various profit centers within the ACTIA industrial Group, where he was in charge of developing new digital activities in France and abroad.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology